"Mark brings a wealth of orthopedic experience to OrthoGrid, and his hands-on leadership style in combination with his proven history of executing value-creating customer programs makes him an excellent fit for our company," noted Richard Boddington, OrthoGrid CEO. "Mark will immediately contribute to OrthoGrid's HipGrid commercialization activities and he will also begin to develop actionable marketing priorities for our orthopedic imaging & guidance R&D pipeline. I am confident that Mark will deliver tremendous value at a very exciting time for OrthoGrid."
Mark joins OrthoGrid from DePuy Synthes, a division of Johnson & Johnson, where he spent seven years leading the company's Hip Replacement surgical approach marketing activities across the USA. Prior to DePuy, Mark enjoyed a successful career with Warner-Chilcott Pharmaceuticals and Organon Pharmaceuticals. Mark earned his BA degree in Economics from Indiana University.